日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhanced nuclear localization of small heterodimer partner in metabolic dysfunction-associated steatohepatitis

代谢功能障碍相关性脂肪性肝炎中小异二聚体伴侣的核定位增强

Chien, Shih-Chieh; Chen, Chiung-Yu; Tsai, Hung-Wen; Lin, Yih-Jyh; Shiesh, Shu-Chu; Cheng, Pin-Nan; Chiu, Hung-Chih; Chiu, Yen-Cheng; Lin, Ya-Han; Wu, Min-Shan; Zheng, Mei-Juan; Young, Kung-Chia; Tsai, Yau-Sheng

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study

直接抗病毒疗法治疗丙型肝炎病毒相关肝细胞癌患者:一项全国性队列研究

Lee, Shou-Wu; Yang, Sheng-Shun; Tsai, Pei-Chien; Huang, Chung-Feng; Chen, Chi-Yi; Hung, Chao-Hung; Chen, Chien-Hung; Tai, Chi-Ming; Cheng, Pin-Nan; Kuo, Hsing-Tao; Tseng, Kuo-Chih; Mo, Lein-Ray; Lo, Ching-Chu; Huang, Yi-Hsiang; Lin, Han-Chieh; Lee, Pei-Lun; Bair, Ming-Jong; Chang, Te-Sheng; Lin, Chun-Yen; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Yang, Tzeng-Hue; Peng, Cheng-Yuan; Yang, Chi-Chieh; Chong, Lee-Won; Huang, Chien-Wei; Lin, Chih-Wen; Chu, Cheng-Hsin; Tsai, Ming-Chang; Kao, Jia-Horng; Liu, Chun-Jen; Chuang, Wan-Long; Lee, Teng-Yu; Yu, Ming-Lung

Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan

台湾全国丙型肝炎病毒登记研究揭示了在合并早期慢性肾病或终末期肾病前期慢性丙型肝炎患者中,普遍采用8周格卡瑞韦/哌仑他韦治疗的真实世界疗效和安全性:

Wang, Szu-Jen; Huang, Chung-Feng; Chang, Te-Sheng; Lo, Ching-Chu; Hung, Chao-Hung; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Bair, Ming-Jong; Lin, Chih-Lang; Yang, Chi-Chieh; Kuo, Hsing-Tao; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Tsai, Pei-Chien; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Tseng, Kuo-Chih; Chen, Chi-Yi; Wang, Shu-Chi; Yu, Ming-Lung

Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan

索非布韦/维帕他韦治疗对2型糖尿病合并慢性丙型肝炎患者肝外表现的影响:来自台湾全国丙型肝炎病毒登记研究的启示

Wang, Szu-Jen; Chang, Te-Sheng; Lo, Ching-Chu; Hung, Chao-Hung; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Bair, Ming-Jong; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Lin, Chih-Lang; Yang, Chi-Chieh; Kuo, Hsing-Tao; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Tsai, Pei-Chien; Wang, Shu-Chi; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Tseng, Kuo-Chih; Chen, Chi-Yi; Huang, Chung-Feng; Yu, Ming-Lung

Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry

丙型肝炎病毒清除对心血管风险的影响:来自台湾全国丙型肝炎病毒登记处的真实世界经验

Hu, Ping-Jen; Tsai, Pei-Chien; Chen, Chi-Yi; Kuo, Hsing-Tao; Hung, Chao-Hung; Tseng, Kuo-Chih; Lai, Hsueh-Chou; Peng, Cheng-Yuan; Wang, Jing-Houng; Chen, Jyh-Jou; Lee, Pei-Lun; Chien, Rong-Nan; Yang, Chi-Chieh; Lo, Gin-Ho; Kao, Jia-Horng; Liu, Chun-Jen; Liu, Chen-Hua; Yan, Sheng-Lei; Lin, Chun-Yen; Su, Wei-Wen; Chu, Cheng-Hsin; Chen, Chih-Jen; Tung, Shui-Yi; Tai, Chi-Ming; Lin, Chih-Wen; Lo, Ching-Chu; Cheng, Pin-Nan; Chiu, Yen-Cheng; Wang, Chia-Chi; Cheng, Jin-Shiung; Tsai, Wei-Lun; Lin, Han-Chieh; Huang, Yi-Hsiang; Yeh, Ming-Lun; Huang, Chung-Feng; Hsieh, Meng-Hsuan; Huang, Jee-Fu; Dai, Chia-Yen; Chung, Wan-Long; Wang, Yen-Hsiange; Yu, Ming-Lung; Bair, Ming-Jong

Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy

二甲双胍和他汀类药物可降低抗病毒治疗失败的慢性丙型肝炎患者发生肝细胞癌的风险

Tsai, Pei-Chien; Huang, Chung-Feng; Yeh, Ming-Lun; Hsieh, Meng-Hsuan; Kuo, Hsing-Tao; Hung, Chao-Hung; Tseng, Kuo-Chih; Lai, Hsueh-Chou; Peng, Cheng-Yuan; Wang, Jing-Houng; Chen, Jyh-Jou; Lee, Pei-Lun; Chien, Rong-Nan; Yang, Chi-Chieh; Lo, Gin-Ho; Kao, Jia-Horng; Liu, Chun-Jen; Liu, Chen-Hua; Yan, Sheng-Lei; Lin, Chun-Yen; Su, Wei-Wen; Chu, Cheng-Hsin; Chen, Chih-Jen; Tung, Shui-Yi; Tai, Chi-Ming; Lin, Chih-Wen; Lo, Ching-Chu; Cheng, Pin-Nan; Chiu, Yen-Cheng; Wang, Chia-Chi; Cheng, Jin-Shiung; Tsai, Wei-Lun; Lin, Han-Chieh; Huang, Yi-Hsiang; Chen, Chi-Yi; Huang, Jee-Fu; Dai, Chia-Yen; Chung, Wan-Long; Bair, Ming-Jong; Yu, Ming-Lung

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program

人工智能预测丙型肝炎病毒患者直接抗病毒药物治疗失败:一项全国性丙型肝炎病毒登记计划

Lu, Ming-Ying; Huang, Chung-Feng; Hung, Chao-Hung; Tai, Chi-Ming; Mo, Lein-Ray; Kuo, Hsing-Tao; Tseng, Kuo-Chih; Lo, Ching-Chu; Bair, Ming-Jong; Wang, Szu-Jen; Huang, Jee-Fu; Yeh, Ming-Lun; Chen, Chun-Ting; Tsai, Ming-Chang; Huang, Chien-Wei; Lee, Pei-Lun; Yang, Tzeng-Hue; Huang, Yi-Hsiang; Chong, Lee-Won; Chen, Chien-Lin; Yang, Chi-Chieh; Yang, Sheng-Shun; Cheng, Pin-Nan; Hsieh, Tsai-Yuan; Hu, Jui-Ting; Wu, Wen-Chih; Cheng, Chien-Yu; Chen, Guei-Ying; Zhou, Guo-Xiong; Tsai, Wei-Lun; Kao, Chien-Neng; Lin, Chih-Lang; Wang, Chia-Chi; Lin, Ta-Ya; Lin, Chih-Lin; Su, Wei-Wen; Lee, Tzong-Hsi; Chang, Te-Sheng; Liu, Chun-Jen; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wan-Long; Peng, Cheng-Yuan; Tsai, Chun-Wei-; Chen, Chi-Yi; Yu, Ming-Lung

Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases

台湾肝病学会-台湾心脏学会关于代谢功能障碍相关脂肪肝和心血管疾病管理的立场声明

Cheng, Pin-Nan; Chen, Wen-Jone; Hou, Charles Jia-Yin; Lin, Chih-Lin; Chang, Ming-Ling; Wang, Chia-Chi; Chang, Wei-Ting; Wang, Chao-Yung; Lin, Chun-Yen; Hung, Chung-Lieh; Peng, Cheng-Yuan; Yu, Ming-Lung; Chao, Ting-Hsing; Huang, Jee-Fu; Huang, Yi-Hsiang; Chen, Chi-Yi; Chiang, Chern-En; Lin, Han-Chieh; Li, Yi-Heng; Lin, Tsung-Hsien; Kao, Jia-Horng; Wang, Tzung-Dau; Liu, Ping-Yen; Wu, Yen-Wen; Liu, Chun-Jen

An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan

基于台湾全国数据的简化丙型肝炎病毒治疗算法(无需专科医生诊治)

Yu, Ming-Lung; Tai, Chi-Ming; Mo, Lein-Ray; Kuo, Hsing-Tao; Huang, Chung-Feng; Tseng, Kuo-Chih; Lo, Ching-Chu; Bair, Ming-Jong; Wang, Szu-Jen; Huang, Jee-Fu; Yeh, Ming-Lun; Chen, Chun-Ting; Tsai, Ming-Chang; Huang, Chien-Wei; Lee, Pei-Lun; Yang, Tzeng-Hue; Huang, Yi-Hsiang; Chong, Lee-Won; Chen, Chien-Lin; Yang, Chi-Chieh; Hung, Chao-Hung; Yang, Sheng-Shun; Cheng, Pin-Nan; Hsieh, Tsai-Yuan; Hu, Jui-Ting; Wu, Wen-Chih; Cheng, Chien-Yu; Chen, Guei-Ying; Zhou, Guo-Xiong; Tsai, Wei-Lun; Kao, Chien-Neng; Lin, Chih-Lang; Wang, Chia-Chi; Lin, Ta-Ya; Lin, Chih-Lin; Su, Wei-Wen; Lee, Tzong-Hsi; Chang, Te-Sheng; Liu, Chun-Jen; Dai, Chia-Yen; Chen, Chi-Yi; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wan-Long; Peng, Cheng-Yuan

Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

台湾全国丙型肝炎登记研究:格卡瑞韦/哌仑他韦通用方案8周治疗初治丙型肝炎患者的真实世界疗效和安全性

Yang, Chun-Chi; Huang, Chung-Feng; Chang, Te-Sheng; Lo, Ching-Chu; Hung, Chao-Hung; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Bair, Ming-Jong; Lin, Chih-Lang; Yang, Chi-Chieh; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Kuo, Hsing-Tao; Tsai, Pei-Chien; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Tseng, Kuo-Chih; Chen, Chi-Yi; Yu, Ming-Lung